Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Simukai Shamu, Patience Shamu, Sikhulile Khupakonke, Thato Farirai, Thato Chidarikire, Geoffrey Guloba & Nkhensani Nkhwashu. (2021) Pre-exposure prophylaxis (PrEP) awareness, attitudes and uptake willingness among young people: gender differences and associated factors in two South African districts. Global Health Action 14:1.
Read now
Read now
Kim Engler, Andras Lènàrt, David Lessard, Isabelle Toupin & Bertrand Lebouché. (2018) Barriers to antiretroviral therapy adherence in developed countries: a qualitative synthesis to develop a conceptual framework for a new patient-reported outcome measure. AIDS Care 30:sup1, pages 17-28.
Read now
Read now
Santosh Kumar, Mengyao Jin, Anusha Ande, Namita Sinha, Peter S Silverstein & Anil Kumar. (2012) Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes. Expert Opinion on Drug Metabolism & Toxicology 8:11, pages 1363-1375.
Read now
Read now
Sibhatu Biadgilign, Amare Deribew, Alemayehu Amberbir & Kebede Deribe. (2009) Barriers and facilitators to antiretroviral medication adherence among HIV-infected paediatric patients in Ethiopia: A qualitative study. SAHARA-J: Journal of Social Aspects of HIV/AIDS 6:4, pages 148-154.
Read now
Read now
LoraL. Sabin, Mary Bachman Desilva, DavidsonH. Hamer, Xu Keyi, Yuan Yue, Fan Wen, Li Tao, HaraldK. Heggenhougen, Lewis Seton, IraB. Wilson & ChristopherJ. Gill. (2008) Barriers to adherence to antiretroviral medications among patients living with HIV in southern China: a qualitative study. AIDS Care 20:10, pages 1242-1250.
Read now
Read now
Shiela M. Strauss, Janetta M. Astone, Corrine Munoz-Plaza, Holly Hagan & Don Des Jarlais. (2005) Residential Substance User Treatment Programs as Venues for HCV Pharmacological Treatment: Client and Staff Perspectives. Substance Use & Misuse 40:12, pages 1811-1829.
Read now
Read now
Articles from other publishers (22)
Kaley Parchinski, Angela Di Paola, Allison P. Wilson & Sandra A. Springer. (2023) The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV. Drug and Alcohol Dependence Reports 7, pages 100159.
Crossref
Crossref
Horacio Gil, Elena Delgado, Sonia Benito, María Moreno-Lorenzo & Michael M. Thomson. (2022) Factors associated with HIV-1 resistance to integrase strand transfer inhibitors in Spain: Implications for dolutegravir-containing regimens. Frontiers in Microbiology 13.
Crossref
Crossref
Sarah C. Mann, Mary Morrow, Ryan P. Coyle, Stacey S. Coleman, Austin Saderup, Jia-Hua Zheng, Lucas Ellison, Lane R. Bushman, Jennifer J. Kiser, Samantha MaWhinney, Peter L. Anderson & Jose R. Castillo-Mancilla. (2020) Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes Mellitus. JAIDS Journal of Acquired Immune Deficiency Syndromes 85:4, pages 483-488.
Crossref
Crossref
Szu‐Szu Ho, Rosie Stenhouse & Aisha Holloway. (2020) Understanding HIV‐positive drug users’ experiences of taking highly active antiretroviral treatment: Identity–Values–Conscious engagement model. Journal of Clinical Nursing 29:9-10, pages 1561-1575.
Crossref
Crossref
Iris Szu‐Szu Ho, Aisha Holloway & Rosie Stenhouse. (2019) What do HIV‐positive drug users’ experiences tell us about their antiretroviral medication‐taking? An international integrated literature review. Addiction 115:4, pages 623-652.
Crossref
Crossref
Srijita Mondal, Priyanka Ghosh, Dibyendu Biswas & Priti Kumar Roy. (2019) Effect of Alcohol Consumption during Antiretroviral Therapy on HIV-1 Replication: Role of Cytochrome P3A4 Enzyme. International Journal of Mathematical, Engineering and Management Sciences 4:4, pages 922-935.
Crossref
Crossref
Nur Afiqah Mohd Salleh, Lindsey Richardson, Thomas Kerr, Jean Shoveller, Julio Montaner, Adeeba Kamarulzaman & M-J. Milloy. (2018) A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs. Journal of Addiction Medicine 12:4, pages 308-314.
Crossref
Crossref
Angélica Quiroga Garza. (2018) Human immunodeficiency virus: the need of a person-centered counselling. Sociology International Journal 2:1.
Crossref
Crossref
Haochu Li, Gifty Marley, Wei Ma, Chongyi Wei, Mellanye Lackey, Qingyan Ma, Françoise Renaud, Marco Vitoria, Rachel Beanland, Meg Doherty & Joseph D. Tucker. (2016) The Role of ARV Associated Adverse Drug Reactions in Influencing Adherence Among HIV-Infected Individuals: A Systematic Review and Qualitative Meta-Synthesis. AIDS and Behavior 21:2, pages 341-351.
Crossref
Crossref
N. D. Yushchuk, Olga N. Fedyaeva & N. A. Sirota. (2016) Strategy for the assessment of compliance with antiretroviral therapy in patients with HIV infection. Clinical Medicine (Russian Journal) 94:1, pages 42-47.
Crossref
Crossref
Cathy M. Puskas, Jamie I. Forrest, Surita Parashar, Kate A. Salters, Angela M. Cescon, Angela Kaida, Cari L. Miller, David R. Bangsberg & Robert S. Hogg. (2011) Women and Vulnerability to HAART Non-Adherence: A Literature Review of Treatment Adherence by Gender from 2000 to 2011. Current HIV/AIDS Reports 8:4, pages 277-287.
Crossref
Crossref
Karen S. Ingersoll & Jessye Cohen. (2008) The impact of medication regimen factors on adherence to chronic treatment: a review of literature. Journal of Behavioral Medicine 31:3, pages 213-224.
Crossref
Crossref
Rifat A. Atun, Martin McKee, Richard Coker & Ipek Gurol-Urganci. (2008) Health systems’ responses to 25 years of HIV in Europe: Inequities persist and challenges remain. Health Policy 86:2-3, pages 181-194.
Crossref
Crossref
Perry HalkitisJoseph PalamarPreetika Mukherjee. (2008) Analysis of HIV Medication Adherence in Relation to Person and Treatment Characteristics Using Hierarchical Linear Modeling. AIDS Patient Care and STDs 22:4, pages 323-335.
Crossref
Crossref
Natalia Bobrova, Anya Sarang, Raminta Stuikyte & Konstantin Lezhentsev. (2007) Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: A regional overview. International Journal of Drug Policy 18:4, pages 313-318.
Crossref
Crossref
Sigrid CJM Vervoort, Jan CC Borleffs, Andy IM Hoepelman & Mieke HF Grypdonck. (2007) Adherence in antiretroviral therapy: a review of qualitative studies. AIDS 21:3, pages 271-281.
Crossref
Crossref
Andrea Sankar, Carol Golin, Jane M Simoni, Mark Luborsky & Cynthia Pearson. (2006) How Qualitative Methods Contribute to Understanding Combination Antiretroviral Therapy Adherence. JAIDS Journal of Acquired Immune Deficiency Syndromes 43:Supplement 1, pages S54-S68.
Crossref
Crossref
Benedikt Fischer, Jens Reimer, Michelle Firestone, Kate Kalousek, Juergen Rehm & Jenny Heathcote. (2006) Treatment for hepatitis C virus and cannabis use in illicit drug user patients: implications and questions. European Journal of Gastroenterology & Hepatology 18:10, pages 1039-1042.
Crossref
Crossref
Claire E. Sterk, Katherine P. Theall & Kirk W. Elifson. 2012. Women and Depression. Women and Depression
382
414
.
Perry N. HalkitisAlexandra H. Kutnick & Simon Slater. (2016) The Social Realities of Adherence to Protease Inhibitor Regimens: Substance Use, Health Care and Psychological States. Journal of Health Psychology 10:4, pages 545-558.
Crossref
Crossref
Jeffrey T. ParsonsElana RosofJoseph C. PunzalanLauren Di Maria. (2005) Integration of Motivational Interviewing and Cognitive Behavioral Therapy to Improve HIV Medication Adherence and Reduce Substance Use Among HIV-Positive Men and Women: Results of a Pilot Project. AIDS Patient Care and STDs 19:1, pages 31-39.
Crossref
Crossref
S. A. Springer, E. Pesanti, J. Hodges, T. Macura, G. Doros & F. L. Altice. (2004) Effectiveness of Antiretroviral Therapy among HIV-Infected Prisoners: Reincarceration and the Lack of Sustained Benefit after Release to the Community. Clinical Infectious Diseases 38:12, pages 1754-1760.
Crossref
Crossref